A phase 1 dose-escalation study: safety, tolerability, and pharmacokinetics of FBS0701, a novel oral iron chelator for the treatment of transfusional iron overload

類似資料

• A phase 2 study of the safety, tolerability, and pharmacodynamics of FBS0701, a novel oral iron chelator, in transfusional iron overload
  著者:: Neufeld, Ellis J., 等
  出版事項: (2012)
• Management of transfusional iron overload – differential properties and efficacy of iron chelating agents
  著者:: Kwiatkowski, Janet L
  出版事項: (2011)
• Iron-Chelating Therapy for Transfusional Iron Overload
  著者:: Brittenham, Gary M.
  出版事項: (2011)
• Oral chelators deferasirox and deferiprone for transfusional iron overload in thalassemia major: new data, new questions
  著者:: Neufeld, Ellis J.
  出版事項: (2006)
• Antimalarial Iron Chelator FBS0701 Blocks Transmission by Plasmodium falciparum Gametocyte Activation Inhibition
  著者:: Ferrer, Patricia, 等
  出版事項: (2015)